Enforcement Report - Week of September 12, 2018
Versapharm's Generic Fluocinolone Acetonide Approved In US
Versapharm's Generic Voriconazole Approved In US
Akorn, Inc., a leading specialty pharmaceutical company, has launched the recently-approved 30 mg strength of Myorisan (isotretinoin capsules, USP). This launch further builds the Myorisan product portfolio that also includes 10 mg, 20 mg and 40 mg capsules.nnAkorn's Myorisan in 10 mg, 20 mg, 30 mg and 40 mg strengths, marketed under the VersaPharm label, are indicated for the treatment of severe recalcitrant nodular acne.
Versapharm`s Generic Fluocinolone Acetonide (0.01% Topical) Approved in US For Itching and Inflammation of the Skin